Emotional Numbing, Medication, Grey Rock, and Substances: Distinguishing Care, Protection, and Avoidance

Pharmacological and safety note. This guide offers general information, not individual medical advice. Do not start, change, or discontinue any psychiatric medication on the basis of this article. Adverse effects, emotional blunting, or doubts about treatment must be discussed with the prescriber. Abrupt discontinuation can cause withdrawal symptoms and increase the risk of relapse. A biblical metaphor is not a diagnosis. In case of immediate risk, seek help right away: call your local emergency number, go to the nearest emergency department, or contact an official crisis service in your country.

This is the fourth guide in the series on Ezekiel 36. Guide 3 distinguished distress from disorder, regulation from avoidance. Here we address more technical ground: medications, relational strategies, and substances, with their differences of function and of risk.

In brief

Not every emotional reduction is pathological and not every emotional intensity is health. The central criterion is whether an intervention increases safety, clarity, functioning, and freedom. Psychiatric medications do not have the general purpose of making people insensitive; they can reduce severe symptoms and restore contact with reality, but they can also produce unwanted effects. Grey Rock is a limited communication strategy, not a validated therapy. Substances can be used as self-medication, but immediate relief can feed dependence and worsen the problem.

The criterion is not "feeling more or less"

Two people can report feeling calmer while being in opposite conditions.

The first, after an effective intervention, sleeps, thinks more clearly, returns to work, and is able to talk about problems without being overwhelmed.

The second is sedated, disconnected, feels no interest, cannot concentrate, and does not recognize themselves.

The quantity of emotion is not enough to evaluate the outcome. One must consider:

• adherence to reality;
• decision-making capacity;
• daily functioning;
• the quality of relationships;
• safety;
• adverse effects;
• the possibility of living according to one's values.

What psychiatric medications actually do

"Psychiatric medication" is a very broad category. Antidepressants, antipsychotics, mood stabilizers, benzodiazepines, and other medicines have different indications, mechanisms, benefits, and risks.

It is not scientifically correct to say that psychiatry uses medications with the general purpose of diminishing understanding and contact with reality.

Antipsychotics, for example, are used to reduce psychotic symptoms such as hallucinations, delusions, and disorganization. The National Institute of Mental Health reports that they can make symptoms less intense and less frequent. In this context, treatment can improve contact with reality, while having possible side effects that require monitoring.

Antidepressants are used in conditions such as depression and some anxiety disorders. A depression can already produce anhedonia, slowing, detachment, and loss of motivation. An effective treatment can restore affective capacity and functioning.

Emotional blunting is a real, but complex, phenomenon

Some people undergoing antidepressant treatment report that positive and negative emotions become attenuated: they find it difficult to cry, rejoice, feel affection, or feel involved. This phenomenon is called emotional blunting.

The scientific literature recognizes the problem, but the causality is not always simple. Blunting can be:

• an effect of the medication;
• a residual symptom of the depression;
• a combination of both;
• influenced by the dose and by individual characteristics.

Therefore the statement "the medication makes me insensitive" must be taken seriously, but not automatically turned into a causal diagnosis.

It is useful to describe to the physician observable elements:

• when the detachment began;
• whether it changed after a change in dose;
• which emotions have diminished;
• which functions have improved or worsened;
• whether other depressive symptoms persist;
• how much relationships and work are affected.

Shared decision-making

Modern guidelines recommend shared decision-making: professional and patient discuss expected benefits, risks, alternatives, preferences, and goals.

The patient is not required to passively accept a treatment that significantly compromises quality of life. At the same time, it is not safe to change the dose on one's own because an effect is unpleasant.

The possible clinical decisions — gradual reduction, change of molecule, treatment of residual symptoms, psychotherapy, monitoring — depend on the case and belong to the relationship with the prescriber.

Why abrupt discontinuation is risky

The NICE guidelines on medicines associated with dependence or withdrawal symptoms include antidepressants, benzodiazepines, Z-drugs, opioids, and gabapentinoids. In many cases a gradual and personalized reduction is necessary.

Withdrawal symptoms can include physical and psychological alterations and can be confused with a relapse. The risk and the manner of reduction vary according to the medication, the dose, the duration, and the person.

The practical rule is precise:

An unwanted effect is a reason to contact the physician, not to improvise a discontinuation.

Sedation and containment in a crisis

In some acute situations, rapidly reducing agitation, severe insomnia, or risk can be a temporary clinical goal. Containment is not necessarily the final destination, but it can create the conditions for a more complete assessment and treatment.

It is incorrect to judge a treatment only from a snapshot of the first hours or first days. It is equally incorrect to normalize a persistent sedation that prevents the person from functioning. Benefits and effects must be reassessed.

Grey Rock: what it is and what it is not

The Grey Rock Method is an informal strategy for certain interactions with manipulative or provocative people. It consists in responding in a brief, neutral, and disengaged manner, avoiding emotional reactions that would feed the conflict.

It is important to clarify:

• it is not a standardized psychotherapy;
• it is not a treatment for a mental disorder;
• the published clinical evidence is limited;
• it does not necessarily change the other person;
• it can be exhausting if used for a long time;
• in some abusive situations it can provoke escalation.

Grey Rock concerns what is communicated in a specific relationship, not an obligation to feel nothing. A person can feel fear or anger and choose not to show them to someone who might use them against them.

The distinction is this:

• boundary: "I will not hand you a reaction you can manipulate";
• generalized petrification: "I will no longer show or feel anything with anyone."

When there is violence or risk, the priority is not to apply a communication technique perfectly, but to build a safety plan and involve competent services.

Substances as self-medication

Alcohol and drugs can be used to rapidly change one's mental state:

• to sleep;
• to not think;
• to attenuate anxiety or shame;
• to dissociate from memories;
• to feel temporarily safe or powerful;
• to reduce loneliness.

Immediate relief can reinforce the behavior: the person learns that the substance is the fastest way to interrupt the experience. Over time, tolerance, loss of control, physical and social consequences, and a substance use disorder can develop.

The National Institute on Drug Abuse emphasizes that substance use disorders and other mental disorders frequently co-occur and that, when present together, it is generally preferable to treat both.

Not all drugs make people insensitive. Some increase euphoria, fear, impulsivity, paranoia, or perceptual alterations. The common denominator is not always anesthesia, but the use of a substance as the main regulator of one's mental state, with increasing risks.

Marta: three ways of "not feeling"

Marta experienced three very different forms of emotional reduction.

1. During a crisis she used grounding and telephoned a friend. The intensity decreased enough to avoid an impulsive act. This was functional containment.
2. With a medication she noticed less despair, but also a marked loss of affect and motivation. She reported the change to the physician, who reassessed the treatment. This was a possible effect to be examined clinically.
3. She began to drink every evening in order not to think. The relief lasted only a few hours, and the next day anxiety and functioning worsened. This was a risky self-medication behavior.

Calling all three experiences "anesthesia" would have prevented us from distinguishing their function, their risk, and the appropriate response.

The Christian and clinical criteria can converge

The spiritual question is: does this choice lead me toward truth, responsibility, love, and freedom?

The clinical question is: does it increase safety, functioning, contact with reality, and the capacity to choose?

The two questions are not identical, but they often converge. A strategy that produces falsehood, dependence, disorganization, and harm hardly represents a freer heart. A treatment that restores clarity and the possibility of living can be welcomed without regarding it as a competitor of the Spirit.

For practice: preparing a description for the physician

Before the appointment, note down:

1. symptoms before treatment;
2. observed benefits;
3. unwanted effects;
4. start date and relationship with the doses;
5. impact on sleep, work, affect, and safety;
6. specific questions to discuss.

Continue the series

• The Heart of Stone and Emotional Suffering — what Ezekiel 36 can and cannot say about mental health.
• Living with a Heart of Flesh — a daily practice of faith, discernment, and safety.

Sources & References

• National Institute for Health and Care Excellence, Depression in adults: treatment and management (NG222).
• National Institute for Health and Care Excellence, Medicines associated with dependence or withdrawal symptoms (NG215).
• National Institute for Health and Care Excellence, Shared decision making (NG197).
• National Institute of Mental Health, Understanding Psychosis and Mental Health Medications.
• Ma H. et al., "Emotional Blunting in Patients With Major Depressive Disorder," Frontiers in Psychiatry, 2021 (PMC).
• Goodwin G.M. et al., "Emotional blunting with antidepressant treatments," Journal of Affective Disorders, 2017 (PubMed).
• National Institute on Drug Abuse, Co-Occurring Disorders and Health Conditions and Treatment.
• Cleveland Clinic, How the Grey Rock Method Works, a clinical-educational source on the purpose and limits of the strategy; it does not constitute proof of therapeutic efficacy.